Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
3.
Int J Antimicrob Agents ; 32(6): 499-504, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18801646

RESUMO

Meticillin-resistant Staphylococcus aureus (MRSA) is a very significant agent of recalcitrant healthcare-associated infections. A major risk of acquiring such infections is thought to be modulated by the use of particular antimicrobial therapies. The aim of this research was to evaluate prospectively the impact of using either ciprofloxacin or Tazocin (piperacillin+tazobactam) on the incidence of MRSA in an Intensive Care Unit (ICU). The 1-year (2 x 6 months) cross-over study was carried out in a medium-sized (426 beds) teaching hospital. During the first 6-month period, ciprofloxacin was used as the first-line broad-spectrum antibiotic therapy of choice. During the second 6-month period, Tazocin was used as first-line therapy. The incidence of hospital-acquired MRSA (i.e. colonised and/or infected) and rates of compliance of the ICU healthcare workers to optimal hand hygiene practices were recorded throughout the study. The study observed no statistically significant differences (P = 0.1) between MRSA incidence rates in the ICU during the ciprofloxacin (4.4/1000 bed-days) or Tazocin (11.4/1000 bed-days) arms of the study. Interestingly, observing healthcare workers' hand hygiene practices throughout the entire study showed that healthcare workers adhered to these practices 59.2% of the time during the ciprofloxacin arm and 66.0% during the Tazocin arm. The low incidence rates within the unit demonstrated the importance of infection control in limiting the spread of MRSA despite the extensive use of antibiotics in a high-risk setting.


Assuntos
Antibacterianos/uso terapêutico , Ciprofloxacina/uso terapêutico , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Unidades de Terapia Intensiva , Staphylococcus aureus Resistente à Meticilina , Ácido Penicilânico/análogos & derivados , Piperacilina/uso terapêutico , Infecções Estafilocócicas/epidemiologia , Infecções Estafilocócicas/prevenção & controle , Interpretação Estatística de Dados , Combinação de Medicamentos , Eletroforese em Gel de Campo Pulsado , Desinfecção das Mãos , Higiene , Ácido Penicilânico/uso terapêutico , Recursos Humanos em Hospital , Combinação Piperacilina e Tazobactam , Infecções Estafilocócicas/microbiologia , Tazobactam , Inibidores de beta-Lactamases
4.
Leuk Lymphoma ; 46(4): 611-4, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16019492

RESUMO

A 42-year-old male patient with a history of diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) developed a central line-related bacteremia due to the presence of a Gram-negative bacillus, which was difficult to identify conventionally. Sequencing of a partial region of the 16S rRNA gene identified the organism as Roseomonas mucosa with a homology score of 100% with 1003 bases called. Due to difficulties with the phenotypic identification of this genus, coupled with its emergence in line-related bacteremia in hematology patients with malignancy, Roseomonas spp. should be considered in cases of line-related infection in such patients with atypical Gram-negative organisms. Although several cases have been reported in the literature of line-related sepsis due to Roseomonas gilardii, only a few cases have been reported of Roseomonas mucosa infection in patients with hematological malignancy. This report highlights the benefits of the integration of a sequence-based typing approach in the identification of difficult-to-identify bacterial isolates employing partial regions of the 16S rRNA gene. Continued routine adoption of such techniques by clinical diagnostic laboratories may prove beneficial for the correct identification of blood-borne infections, as well as for the correct epidemiological characterization of unusual causal agents of bacteremia in immunocompromised individuals.


Assuntos
Bacteriemia/microbiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Linfoma de Células B/complicações , Linfoma Difuso de Grandes Células B/complicações , Methylobacteriaceae/isolamento & purificação , Adulto , Bacteriemia/complicações , Humanos , Linfoma de Células B/terapia , Linfoma Difuso de Grandes Células B/terapia , Masculino , Methylobacteriaceae/genética , RNA Ribossômico 16S/genética , Indução de Remissão , Especificidade da Espécie
5.
Mycopathologia ; 154(1): 25-8, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12041868

RESUMO

Edible dates (Phoenix dactylifera) were examined for the presence of endogenous yeasts and filimentous fungi. Mean counts of fungi were 530 colony forming units (cfu) per gram of fruit, representing a mixture of two phenotypic colony types. Subsequent DNA extraction and PCR amplification of these two morphotypes yielded an amplicon of approximately 350 bp with the 5.8S-28S rRNA ITS region. Sequence analysis identified these to be Cladosporium cladosporioides (230 cfu/g) and Sporobolomyces roseus. Both organisms have been previously reported in opportunistic infections involving skin or in immunocompromised patients. This is the first report of edible dates being a source of these organisms and we emphasize the importance of the common practice of washing hands following the consumption of these fruits by hand.


Assuntos
Basidiomycota/isolamento & purificação , Cladosporium/isolamento & purificação , Frutas/microbiologia , Controle Biológico de Vetores/métodos , Arecaceae/microbiologia , Basidiomycota/crescimento & desenvolvimento , Cladosporium/crescimento & desenvolvimento , Microbiologia de Alimentos , Genes de RNAr , Humanos , Infecções Oportunistas/microbiologia , Reação em Cadeia da Polimerase , Saúde Pública , Análise de Sequência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA